The effect of sequence variations and structure on the cytolytic activity of melittin peptides.
The importance of various amino acid residues in melittin for cytolytic function against mammalian cells was assessed by use of a monoclonal antibody to the C-terminal region, synthesis of peptide analogues and chemical modification of specific residues. A monoclonal anti-melittin antibody directed to the basic C-terminal region inhibited cytolytic activity. Consistent with this, deletion of one of the two Lys Arg sequences at the C terminal end of the peptide reduced cytolysis 8-fold, although significant activity was still present. A similar reduction in activity was also found with a synthetic analogue which had the reverse sequence to melittin. In contrast, when the last 6 residues of the C-terminal region were transferred to the N-terminus, a peptide with markedly reduced activity was obtained. Chemical modification of lysine and arginine residues of melittin indicated that lysine was only minimally important for functional activity compared with arginine which was essential. In particular, our results demonstrate that substitution of serine for lysine 7 has no significant effect on the activity of the peptide and suggest that this residue is important only in maintaining the amphipathic helix of the peptide.
CSIRO, Division of Biomolecular Engineering, Parkville, Victoria, Australia.
J A
JA
Werkmeister
A
A
Kirkpatrick
J A
JA
McKenzie
D E
DE
Rivett
D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal; D001120:Arginine / Q000494:pharmacology; D005260:Female; D006801:Humans; D008239:Lysine / Q000494:pharmacology; D008555:Melitten / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000494:pharmacology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D017384:Sequence Deletion; D013329:Structure-Activity Relationship; D014407:Tumor Cells, Cultured
D000911:Antibodies, Monoclonal; D008555:Melitten; D001120:Arginine; D008239:Lysine